Tumors. a. Chemotherapy of ovarian cancer
Ochiai, K.
Nihon Sanka Fujinka Gakkai Zasshi 46(8): 821-831
1994
ISSN/ISBN: 0300-9165 PMID: 8089618 Document Number: 430184
Document emailed within 1 workday
Related Documents
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177Kunze, M.; Büttner, H.H.; Strache, R.R.; Voss, P.; Briese, V.; Schrodt, U. 1988: CEA determination in aspired fluid of cystic ovarian tumors and ovarian cysts and in ascites and serum samples of patients with ovarian tumors Zentralblatt für Gynakologie 110(16): 1006-1012
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Jin, Z.; Gu, J.; Xin, X.; Li, Y.; Wang, H. 2014: Expression of hexokinase 2 in epithelial ovarian tumors and its clinical significance in serous ovarian cancer European Journal of Gynaecological Oncology 35(5): 519-524
Jacobs, I.J.; Smith, S.A.; Wiseman, R.W.; Futreal, P.A.; Harrington, T.; Osborne, R.J.; Leech, V.; Molyneux, A.; Berchuck, A.; Ponder, B.A. 1993: A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus Cancer Research 53(6): 1218-1221
Murakami, F.; Kiyozuka, Y.; Nishimura, H.; Imamura, K.; Yakushiji, M.; Noda, T.; Adachi, S.; Ito, K.; Tamori, N.; Shintani, M. 1993: Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro Nihon Sanka Fujinka Gakkai Zasshi 45(2): 125-132
Studzinski, Z.; Zajewski, W. 2002: Bilateral metastatic ovarian tumors (Krukenberg's tumors) in the course of stomach cancer Archives of Gynecology and Obstetrics 267(2): 95-97
Sampi, K. 1987: Cancer chemotherapy combined with a calcium antagonist in patients with hematologic malignancies and solid tumors resistant to standard chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Part 2): 951-955
Frid, I.A.; Turbina, I.L. 1972: The effect of anesthesia and surgical intervention on hematopoiesis following chemotherapy of malignant ovarian tumors Voprosy Onkologii 18(2): 91
Kusumoto, S.; Naito, H.; Imazu, K.; Kai, I.; Hamasaki, A.; Kazusa, Y.; Nakashima, Y.; Kodama, M.; Kumagai, M.; Ueda, K. 2017: Clinical Study to Determine the Dose Intensity of BEP Chemotherapy for Ovarian Malignant Germ Cell Tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(3): 255-259
Ozols, R.F.; Young, R.C. 1991: Chemotherapy of ovarian cancer Seminars in Oncology 18(3): 222-232
Anselmo-Murphy, A.M. 2009: Challenges of IP chemotherapy for ovarian cancer Oncology 23(11 Suppl Nurse Ed): 21-22
Camci, C.; Balat, O. 2002: Neoadjuvant chemotherapy in ovarian cancer European Journal of Gynaecological Oncology 23(5): 437-441
Onda, T. 2012: Neoadjuvant chemotherapy for ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(6): 882-886
Nishimura, H.; Imamura, K.; Chang, C. 1996: Chemotherapy for recurrent ovarian cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1124-1128
Paulus, A.; Gennigens, C.; Fillet, G.; Loly, C.; Sautois, B. 2007: Chemotherapy of ovarian cancer: state of the art Revue Medicale de Liege 62(9): 539-547
Wang, J.; Li, A.J.; Karlan, B.Y. 2002: Chemotherapy in epithelial ovarian cancer Current Women's Health Reports 2(1): 20-26
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Gazárek, F.; Kudela, M.; Talas, M.; Fingerová, H. 1976: Possibilities of a directed chemotherapy in ovarian cancer Ceskoslovenska Gynekologie 41(10): 719-721
Lehoczky, O.ó 2005: Neoadjuvant chemotherapy in the treatment of ovarian cancer Orvosi Hetilap 146(38): 1951-1955